(Total Views: 460)
Posted On: 11/09/2017 7:16:23 PM
Post# of 9144
Re: mitstevfel #4001
Scott,--Toxic Financing
At least one piece of good news from that chat is that Brett has resisted toxic financing deals, which most Pink Sheet companies thrive on; and then, after the deal is signed, shareholders get screwed through dilution and usually reverse splits.
So, kudos to Brett for that. Let's hope he can pull off a patent sale for enough money to expand production of the N-Assay test. Still can't understand why that test is not generating interest from large med-tech companies. Anyone have any thoughts on that.
At least one piece of good news from that chat is that Brett has resisted toxic financing deals, which most Pink Sheet companies thrive on; and then, after the deal is signed, shareholders get screwed through dilution and usually reverse splits.
So, kudos to Brett for that. Let's hope he can pull off a patent sale for enough money to expand production of the N-Assay test. Still can't understand why that test is not generating interest from large med-tech companies. Anyone have any thoughts on that.
(3)
(0)
